Reported Apr 27, 2022 · Terminated
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC,…
Mylan Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mylan Pharmaceuticals Inc · 3711 Collins Ferry Rd · Morgantown, WV · 26505-2362
Is this the product you have?
- Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only
- Manufactured forMylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60
- Lot codes and dates
Lot #: 7008990exp. date Dec-20227009025exp. date Feb-202370090857009086exp. date Apr-2023
- Amount recalled
- 33,893 vials
Where it was sold
- Nationwide
Why it was recalled
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.